Clinical trial
Effect of Diet, Exercise and Rosiglitazone on Regional Fat and Insulin Resistance in HIV-Infected and Uninfected Men and Women
NCT00264251 is registered in ClinicalTrials.gov with St. Luke's-Roosevelt Hospital Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Diet, Exercise and Rosiglitazone on Regional Fat and Insulin Resistance in HIV-Infected and Uninfected Men and Women
- Lead sponsor
- St. Luke's-Roosevelt Hospital Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- August 31, 2007
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.